3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioblastoma
23
Brain Neoplasms
16
Central Nervous System Neoplasms
13
Glioma
9
Gliosarcoma
8
Neuroblastoma
7
Astrocytoma
7
Neoplasms
6
Recurrence
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Melanoma
3
Lymphoma
3
Lung Neoplasms
3
Testicular Neoplasms
2
Sarcoma
2
Ovarian Neoplasms
2
Oligodendroglioma
2
Neoplasm Metastasis
2
Meningeal Carcinomatosis
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Acute
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Interventions
Levetiracetam
6
perampanel
2
Tranexamic Acid
2
Standard of Care
2
ziprasidone
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tobramycin
1
Temozolomide
1
Spironolactone
1
Sodium Chloride
1
Sevelamer
1
Saline Solution
1
Rocuronium
1
Pregabalin
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Mental Status and Dementia Tests
1
Magnetic Resonance Spectroscopy
1
Magnesium Sulfate
1
Lurasidone Hydrochloride
1
Labetalol
1
Haloperidol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Seizures
×
Drug Therapy
×
CNS
×
Clear all
NCT04450160
2020-06-29
AEO
MetVital, Inc.
Phase 2
Unknown
80 enrolled